Esterline Technologies Corporation
Esterline Technologies — FY2018 Earnings Presentation
10 slides from Esterline Technologies's earnings presentation, Nov 9, 2017
Slide 1: Capital Allocation at Esterline FY 2018
Capital Allocation at Esterline FY 2018 Exhibit 99.3
Slide 2: Forward-looking statements
This presentation may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance. These forward-looking statements are only predictions based on the current intent and e
Slide 3: Solid, Pressure-tested Balance Sheet
Flexibility to Allocate Capital to Best Use Solid Balance Sheet Strong Free Cash Flow Target debt level: 2.0x to 2.5x gross debt to EBITDA Balance between rate and flexibility Clear runway - no debt maturities until 2020 Patient capital - willingness to retain cash Consistent free cash flow conversi
Slide 4: Capital Allocation: Long-term Shareholder Value Accretion
3 Capital Allocation Long-term Shareholder Value Accretion Consistent Organic Growth Focus R&D CAPEX Opportunistic External Growth Focus Acquisitions Return of Capital
Slide 5: Balanced Capital Deployment 2014-2017
Balanced Capital Deployment 2014-2017 35% R&D Expense Drive long-term organic growth 20% Capital Investment Sustain, grow and reduce cost Acquisitions: Strategic expansion of products and capabilities 18% Share Repurchase Be an opportunistic buyer using a disciplined framework 27% R&D CAPEX Acquisit
Slide 6: R&D – Drive Long-term Organic Growth
R&D – Drive Long-term Organic Growth Customer-facing investment Specific product development for awarded programs Technology roadmaps addressing customer needs & driving long-term organic growth Internal investment with attractive risk/return profile Consistent Investment: ~5% of Sales
Slide 7: CAPEX – Sustain & Grow the Existing Business
CAPEX– Sustain & Grow the Existing Business Maintain and enhance competitive position of existing businesses Maintain/upgrade/enhance operational capabilities Improve efficiency Enhance margins 6 Consistent Investment: $60M - $70M / year
Slide 8: Focused & Disciplined External Investment
Focused & Disciplined External Investment Economics – IRR > risk adjusted cost of capital, accretive on a cash earnings basis Strategic Fit – current core markets, meaningful scale, complementary technology/products Opportunity – leverage ESL infrastructure, hard $ synergies, enhance competitive pos
Slide 9: Return Capital to Shareholders - Considerations
Return Capital to Shareholders - Considerations Opportunistic & disciplined share repurchase Provide superior risk-adjusted return to capital allocation alternatives including M&A Made at a discount to intrinsic value AND Made at a relative discount to peer/market valuations Modest repurchase design
Slide 10: Appendix – Non-GAAP Financial Measures
Appendix – Non-GAAP Financial Measures 9 Free Cash Flow Reconciliation FY 2014 Recast FY 2015 FY 2016 FY 2017 Total Cash Flow from Operations $ 216 $ 194 $ 167 $ 193 $ 770 Capital Expenditures (46) (55) (68) (58) (227) Free Cash Flow * $ 170 $ 139 $ 99 $ 135 $ 543 Net Earnings $ 102 $ 88 $ 102 $ 117
Esterline Technologies — FY2018 Earnings Presentation on 6ix